Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Metastatic Castration-resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Early research (Phase 1)Looking for participantsNCT04729114
What this trial is testing

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration Resistant Prostate CancerMetastatic Castration-sensitive Prostate Cancer
Astellas Pharma Global Development, Inc. 174
Early research (Phase 1)Study completedNCT04397276
What this trial is testing

JNJ-70218902 in Participants With Advanced Stage Solid Tumors

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Ended earlyNCT03572478
What this trial is testing

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Who this might be right for
Prostate CancerEndometrial Cancer
University of Chicago 12
Not applicableUnknownNCT02787837
What this trial is testing

PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.

Who this might be right for
Advanced Prostate CancerAbiraterone ACetate
Centro Nacional de Investigaciones Oncologicas CARLOS III 220
Not applicableUnknownNCT02925702
What this trial is testing

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.

Who this might be right for
Advanced Prostate CancerCastration ResistantRadium 223
Centro Nacional de Investigaciones Oncologicas CARLOS III 161
Early research (Phase 1)Study completedNCT01607905
What this trial is testing

Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer

Who this might be right for
Solid Tumor
Karyopharm Therapeutics Inc 192
Testing effectiveness (Phase 2)Ended earlyNCT00293371
What this trial is testing

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 6
Testing effectiveness (Phase 2)Study completedNCT00706498
What this trial is testing

Phase II Study of BI 2536 in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 20
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT03568656
What this trial is testing

Study to Evaluate CCS1477 in Advanced Tumours

Who this might be right for
Metastatic Castration-Resistant Prostate CancerMetastatic Breast CancerNon-small Cell Lung Cancer+1 more
CellCentric Ltd. 219
Early research (Phase 1)Looking for participantsNCT07277270
What this trial is testing

GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 83
Not applicableWithdrawnNCT01692483
What this trial is testing

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Neoplasms
Janssen Pharmaceutica
Testing effectiveness (Phase 2)Ended earlyNCT03577028
What this trial is testing

Study of HPN424 in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Cancer
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 104
Early research (Phase 1)Study completedNCT02655822
What this trial is testing

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

Who this might be right for
Renal Cell CancerMetastatic Castration Resistant Prostate Cancer
Corvus Pharmaceuticals, Inc. 502
Not applicableStudy completedNCT03658486
What this trial is testing

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

Who this might be right for
Prostate Cancer MetastaticCastration-resistant Prostate Cancer
Queen's University, Belfast 30
Early research (Phase 1)UnknownNCT04839991
What this trial is testing

Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.

Who this might be right for
Advanced and/or Metastatic Solid Tumours
Crescendo Biologics Ltd. 70
Early research (Phase 1)Not Yet RecruitingNCT07423117
What this trial is testing

ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

Who this might be right for
Metastatic Castration-resistant Prostate CancerNon-small Cell Lung CancerTriple Negative Breast Cancer+1 more
IntoCell, Inc 102
Testing effectiveness (Phase 2)Looking for participantsNCT05489211
What this trial is testing

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Who this might be right for
Endometrial CancerGastric CancerMetastatic Castration-resistant Prostate Cancer+4 more
AstraZeneca 454
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Next Page